Weekly Venetoclax Summary Is Without Question Beginning To Feel Kind Of Outdated

Similar to Lewis y, the expressions of CD44, CD147, HE4, integrin ��5, ��1, ��v and ��3 were mainly on membrane (Figure 1). Patients were dichotomised into high and low by the median final score of each marker expression. For all the markers, there are significant difference in low and high expression between sensitive group and resistant group (all P Selleckchem Venetoclax (Table 4). However, high Lewis y and CD44 expressions were significantly associated with higher possibilities of residual tumor size > 1 cm (P = 0.010, 0.024, respectively). Figure 1 The expression of Lewis y, CD44, CD147, Human epididymis protein 4 (HE4), integrin ��5, ��1, ��v and ��3 in chemotherapy resistant group and chemotherapy sensitive group of EOC samples. Representative immunostaining for (A, ... Table 3 Expression of Lewis y, CD44, CD147, Integrin ��5, ��1, ��v and ��3 in chemotherapy sensitive MMP23B group and resistant group of 92 cases epithelial ovarian cancer Table 4 Clinical and pathologic characteristics of 92 epithelial ovarian cancer patients and their association to Lewis y, CD44, CD147, HE4, integrin ��5, ��1, ��v, ��3 protein expression Independent risk factors for chemotherapeutic resistant reaction in EOC patients The independent risk factors analysis for all of the clinicopathological variables and the IHC expression associated with chemotherapeutic resistant reaction was performed (Table 5). Regarding these variables, FIGO Stage III-IV, lymph node metastasis and residual tumor size > 1 cm (OR, 7.448, 2.646 and 5.467, respectively, all P Ibrutinib Lewis y, CD44, CD147, HE4, integrin ��5, ��1, ��v and ��3 (OR, 11.471, 8.750, 4.680, 6.882, 6.882, 5.000, 3.788 and 2.870, respectively, all P